Found 6 matching trials
Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of Age
PHASE3This study assesses non-inferiority by comparing seroconversion rate of NBP...
Location
De La Salle Health Sciences Institute
Safety Study of NBP608 in Healthy Adult Volunteers
PHASE1* Indication: Protection against varicella and herpes zoster
* Study Object...
Location
Korea University Guro Hospital
SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years
PHASE3The goal of this study is to evaluate the safety and immunogenicity of an i...
The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age
PHASE2This study evaluates the immunogenicity and safety of three different poten...
Location
Research Insitute for Torpical Medicine
Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over
PHASE3This study assesses non-inferiority by comparing GMR(Geometric Mean Ratio) ...
Location
Korea University Guro Hospital
Immunogenicity and Safety of Two Lots of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over
PHASE2This study assesses non-inferiority by comparing GMR(Geometric Mean Ratio) ...
Location
Korea University Guro Hospital